نتایج جستجو برای: myeloablative conditioning

تعداد نتایج: 48131  

Journal: :Respiratory medicine 2013
C Moermans C Poulet M Henket C Bonnet E Willems F Baron Y Beguin R Louis

BACKGROUND Induced sputum is a non-invasive method to investigate airway inflammation, which has been used to assess pulmonary inflammatory diseases. However, this procedure has not been studied in the context of hematopoietic stem cell transplantation (HSCT). METHODS We monitored lung function in 182 patients who underwent HSCT and measured airway inflammation by sputum induction in 80 of th...

2014

Cord blood transplantation (CBT) from an unrelated donor has been increasingly used as an alternative transplant method for adult patients without human leukocyte antigen (HLA)-compatible related or unrelated donors. However, the main disadvantage of CBT is still the limited cell dose, especially in adults, and this might contribute to a higher incidence of graft failure and delayed hematopoiet...

Journal: :Cytotherapy 2021

Background aimsTo reduce the risk of graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (alloSCT), T-cell depletion (TCD) grafts can be performed by addition alemtuzumab (ALT) “to bag” (in vitro) before transplantation. In this prospective study, authors analyzed effect in vitro incubation with 20 mg ALT on composition prior to graft infusion. Furthermore, assessed whet...

Journal: :Blood 2004
Razvan Diaconescu Christopher R Flowers Barry Storer Mohamed L Sorror Michael B Maris David G Maloney Brenda M Sandmaier Rainer Storb

Nonmyeloablative regimens for allogeneic hematopoietic cell transplantation (HCT) have been developed for patients ineligible for myeloablative conditioning. We compared regimen-related toxicities (RRTs) and nonrelapse mortality (NRM) in 73 nonmyeloablative and 73 myeloablative recipients of HLA-matched related donor HCT, using the National Cancer Institute (NCI) Common Toxicity Criteria. Nonmy...

2002
Reinhard A. Seger Tayfun Gungor Bernd H. Belohradsky Stephane Blanche Pierre Bordigoni Paolo Di Bartolomeo Terence Flood Paul Landais Susanna Müller Hulya Ozsahin Justen H. Passwell Fulvio Porta Shimon Slavin Nico Wulffraat Felix Zintl Arnon Nagler Andrew Cant

Treatment of chronic granulomatous disease (CGD) with myeloablative bone marrow transplantation is considered risky. This study investigated complications and survival according to different risk factors present at transplantation. The outcomes of 27 transplantations for CGD, from 1985 to 2000, reported to the European Bone Marrow Transplant Registry for primary immunodeficiencies were assessed...

2013
Wan-ming Da Yong Da

The substance of bone marrow transplantation is the organ transplantation. Accurately, it is the grafting of hematopoietic and immunologic system. Comparing to the transplantation of solid organ, in the hematopoietic stem cell transplantation (HSCT), the ill organ, id est. hem‐ atopoietic and immunology system, is ablated by high-dose chemotherapy and total body irradiation(TBI) (conditioning r...

2016
Michael M B Green Nelson Chao Saurabh Chhabra Kelly Corbet Cristina Gasparetto Ari Horwitz Zhiguo Li Jagadish Kummetha Venkata Gwynn Long Alice Mims David Rizzieri Stefanie Sarantopoulos Robert Stuart Anthony D Sung Keith M Sullivan Luciano Costa Mitchell Horwitz Yubin Kang

BACKGROUND The binding of CXCR4 with its ligand (stromal-derived factor-1) maintains hematopoietic stem/progenitor cells (HSPCs) in a quiescent state. We hypothesized that blocking CXCR4/SDF-1 interaction after hematopoietic stem cell transplantation (HSCT) promotes hematopoiesis by inducing HSC proliferation. METHODS We conducted a phase I/II trial of plerixafor on hematopoietic cell recover...

Journal: :Haematologica 2017
Shannon R McCurdy Yvette L Kasamon Christopher G Kanakry Javier Bolaños-Meade Hua-Ling Tsai Margaret M Showel Jennifer A Kanakry Heather J Symons Ivana Gojo B Douglas Smith Maria P Bettinotti William H Matsui Amy E Dezern Carol Ann Huff Ivan Borrello Keith W Pratz Douglas E Gladstone Lode J Swinnen Robert A Brodsky Mark J Levis Richard F Ambinder Ephraim J Fuchs Gary L Rosner Richard J Jones Leo Luznik

Composite endpoints that not only encompass mortality and relapse, but other critical post-transplant events such as graft-versus-host disease, are being increasingly utilized to quantify survival without significant morbidity after allogeneic blood or marrow transplantation. High-dose, post-transplantation cyclophosphamide reduces severe graft-versus-host disease with allogeneic marrow transpl...

2015
Monazza Chaudhry Natasha Ali

which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The treatment for hematological malignancies has excelled over the past decade. A vast number of hema-tological malignancies are now amenable to cure with hematopoietic stem cell transplants (HSCTs) [1]. Older patients with comorbidities are poor candidates ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید